Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination.

Heald AE, Fudman EJ, Anklesaria P, Mease PJ; 13G01 Study Team.

J Rheumatol. 2010 May;37(5):1042-8. doi: 10.3899/jrheum.090827. Epub 2010 Mar 15.

PMID:
20231202
2.

Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE.

J Rheumatol. 2010 Apr;37(4):692-703. doi: 10.3899/jrheum.090817. Epub 2009 Dec 23.

PMID:
20032102
4.

Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

Willkens RF, Urowitz MB, Stablein DM, McKendry RJ Jr, Berger RG, Box JH, Fiechtner JJ, Fudman EJ, Hudson NP, Marks CR, et al.

Arthritis Rheum. 1992 Aug;35(8):849-56.

PMID:
1642652
5.

Acromegalic arthropathy. Characteristics and response to therapy.

Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH.

Arthritis Rheum. 1988 Aug;31(8):1022-7.

PMID:
2900639
6.

Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis.

Fudman EJ, Till GO, Fox IH.

J Rheumatol. 1987 Aug;14(4):686-91.

PMID:
2822924
7.

Scleromyxedema with systemic involvement mimics rheumatic diseases.

Fudman EJ, Golbus J, Ike RW.

Arthritis Rheum. 1986 Jul;29(7):913-7.

8.

Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis.

Fudman EJ, Schnitzer TJ.

Semin Arthritis Rheum. 1986 May;15(4):255-60. Review. No abstract available.

9.

Dermatomyositis without creatine kinase elevation. A poor prognostic sign.

Fudman EJ, Schnitzer TJ.

Am J Med. 1986 Feb;80(2):329-32.

10.

Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.

Fudman EJ, Kelling DG Jr.

J Rheumatol. 1985 Dec;12(6):1191-2.

PMID:
4093929
11.

Demonstration of a chemotactic factor receptor on macrophages.

Snyderman R, Fudman EJ.

J Immunol. 1980 Jun;124(6):2754-7.

PMID:
7373048

Supplemental Content

Loading ...
Support Center